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The development of the mammalian pancreas is governed by various signaling processes and by a cascade of gene activation events
controlled by different transcription factors. Here we show that the divergent homeodomain transcription factor Prox1 is a novel, crucial
regulator of mouse pancreas organogenesis. Loss of Prox1 function severely disrupted epithelial pancreas morphology and hindered
pancreatic growth without affecting significantly the genesis of endocrine cells before E11.5. Conversely, the lack of Prox1 activity
substantially decreased the formation of islet cell precursors after E13.5, during a period known as the ‘‘secondary transition’’. Notably, this
defect occurred concurrently with an abnormal increment of exocrine cells. Hence, it is possible that Prox1 contributes to the allocation of an
adequate supply of islet cells throughout pancreas ontogeny by preventing exocrine cell differentiation of multipotent pancreatic progenitors.
Prox1 thus appears to be an essential component of a genetic program destined to produce the cellular complexity of the mammalian
pancreas.
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The murine pancreas arises from two evaginations
(dorsal and ventral) that begin to form at the foregut/midgut
region of the embryo at approximately embryonic day 9
(E9.0). This process is followed by intense growth and
branching and by subsequent rotation and fusion of the
primordia into a single organ (Murtaugh and Melton, 2003;
Slack, 1995). The growth of the pancreatic epithelium is
accompanied by the asynchronous production of distinct
pancreatic cell types: endocrine (alpha, beta, delta, and PP),
exocrine, and ductal cells (Murtaugh and Melton, 2003;
Pictet and Rutter, 1972). Whereas a handful of glucagon-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.07.021
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insulin-producing (beta) cells appear in increasing numbers
beginning at approximately E13.5. In contrast, pancreatic
exocrine cells, somatostatin-producing (delta) cells, and
pancreatic polypeptide-producing (PP) cells start to appear
only shortly thereafter (Pictet and Rutter, 1972; Slack,
1995). This changing character of pancreatic differentiation
probably reflects changes over time in both the inductive
milieu and the potential of pancreatic progenitors. Similarly,
the proliferation of pancreatic progenitor cells also appears
to be governed by complex interactions involving extrinsic
(mesenchymal) cues and intrinsic factors (Edlund, 2002;
Kim and Hebrok, 2001; Murtaugh and Melton, 2003).
Crucial for the characterization of the intricate molecular
mechanisms governing the fate and expansion of pancreatic
progenitors is the identification of key components partic-
ipating in these processes. In recent years and largely in part86 (2005) 182 – 194
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gene functions have been identified that appear to be
necessary for the correct execution of a specific aspect(s) of
pancreas organogenesis (Edlund, 2002; Habener et al.,
2005; Murtaugh and Melton, 2003).
The divergent homeodomain transcription factor Prox1 is
expressed in the mouse pancreatic region even before the
pancreatic bud arises (Burke and Oliver, 2002). Prox1 is also
expressed in various developing tissues where its function
appears to be essential for normal organogenesis (Oliver et
al., 1993). Hence, Prox1 activity is required for specification
of the lymphatic vasculature (Wigle and Oliver, 1999; Wigle
et al., 2002), lens fiber cell differentiation (Wigle et al., 1999),
retinal cell-type specification (Dyer et al., 2003), and hepatic
morphogenesis (Sosa-Pineda et al., 2000). In the study
described here, we characterized the expression of Prox1
throughout the development of the mouse pancreas and
thoroughly analyzed the pancreata of Prox1-nullizygous
embryos. Our results showed that the lack of pancreatic
Prox1 function hindered pancreatic epithelial growth and
disrupted overall pancreas morphology. In addition, Prox1-
deficient pancreata had severe disturbances in endocrine cell
genesis and increased production of exocrine precursors. Our
studies thus unveiled a novel function of Prox1 that not only
seems to impinge on various aspects of pancreas morpho-
genesis, but also appears to be necessary to preserve the
cellular complexity of this organ.Materials and methods
Generation and genotyping of Prox1 mutant mice
Functional inactivation of Prox1 and genotyping of
offspring by PCR or Southern blot analysis of genomic
DNA were previously described (Wigle et al., 1999). The
experimental protocols were approved by the animal care
and use committee at St. Jude Children’s Research Hospital.
Processing of embryos and pancreatic tissues
Tissues of dissected embryos or pancreata of newborn
mice were prepared for immunohistochemical analysis or in
situ hybridization by fixation overnight in 4% paraformal-
dehyde at 4-C. Tissues were then immersed in 30% sucrose
in phosphate-buffered saline (PBS) overnight at 4-C for
cryoprotection, embedded in tissue-freezing medium (Tis-
sue-Tek, Triangle Biomedical Sciences), and cut by a
cryostat into sections (8 Am for immunohistochemical study
and 12 Am for in situ hybridization).
Histologic analysis
E15.0 pancreata were dissected, fixed overnight in 4%
paraformaldehyde, and embedded in paraffin. Sections (5
Am) were stained with hematoxylin and eosin, examined byusing a Zeiss Axioskop 2 microscope, and photographed
with a SPOT digital camera (Diagnostic Instruments).
Detection of b-galactosidase activity
Whole E15.0 embryos (Prox1+/ or Prox1/) or
dissected pancreata of adults (Prox1+/) were incubated
for 60 min at 4-C with fixative solution (1% form-
aldehyde, 0.2% glutaraldehyde, 0.2% NP-40, and 0.1%
SDS in PBS). Tissues or embryos were then washed twice
at room temperature for 20 min with PBS and incubated
overnight at 30-C with staining solution (1 mg/ml X-gal, 5
mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.2%
NP-40, 0.1% SDS in PBS). The digestive tracts of E15.0
embryos were dissected and photographed. Adult pancreata
were washed with 20% and 50% glycerol for 2 h and with
80% glycerol overnight and were then photographed with
a Leica MZFLIII stereomicroscope equipped with a
Hamamatsu C5810 color digital camera (Hamamatsu
Photonics K.K.).
Immunohistochemical analysis
Frozen sections underwent immunohistochemical assays.
Primary antibodies were the following: rabbit anti-a-
amylase (diluted 1:250; Sigma); rabbit anti-h-galactosidase
(1:5000; ICN); mouse anti-bromodeoxyuridine (IgG iso-
type; final concentration, 7 Ag/ml; Becton Dickinson); rabbit
anti-Cdkn1b (1:200; Santa Cruz Biotechnology); rabbit anti-
cholecystokinin (1:50; Lab Vision Corporation); guinea pig
anti-glucagon (1:500; LINCO Research, Inc); guinea pig
anti-insulin (1:250; DAKO); guinea pig anti-Isl1 (1:4000;
provided by T. Jessell); mouse anti-Ki67 (1:50; Pharmin-
gen); rat anti-laminin (1:200; BIODESIGN); guinea pig
anti-Ngn3 (1:2000; provided by M. German); rabbit anti-
Nkx2.2 (1:1000; provided by T. Jessell); rabbit anti-Nkx6.1
(1:1000; provided by P. Serup); rabbit anti-p48 (1:400;
provided by H. Edlund); rabbit anti-Pax6 (1:1000; Covance
Research Products); rabbit anti-phospho-histone3 (1:2000;
Upstate Biotechnology); rabbit anti-Pdx1 (1:1000; provided
by C. Wright); goat anti-Pdx1 (1:10,000; provided by C.
Wright); rabbit anti-Prox1 (1:5000; Covance Research
Products); guinea-pig anti-Prox1 (1:500); goat anti-soma-
tostatin (1:250; Santa Cruz Biotechnology); and rat anti-
uvomorulin/E-cadherin (1:1000; Sigma). The following
secondary antibodies (diluted 1:200) were used for detec-
tion: Cy3-conjugated donkey anti-guinea pig IgG (Jackson
ImmunoResearch Laboratories, Inc.); Cy3-conjugated don-
key anti-mouse IgG (Jackson); Cy3-conjugated donkey anti-
rabbit IgG (Jackson); Cy3-conjugated donkey anti-rat IgG
(Jackson); Alexa 488-conjugated goat anti-rabbit IgG
(Molecular Probes); Alexa 488-conjugated goat anti-rat
IgG (Molecular Probes); Alexa 488-conjugated goat anti-
guinea pig IgG (Molecular Probes); and Alexa 488-
conjugated donkey anti-goat IgG (Molecular Probes).
Biotinylated donkey anti-rabbit IgG (Jackson) was detected
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Laboratories). For nuclear staining, sections were covered
with mounting medium containing 4V,6-diamidino-2-phe-
nylindole (DAPI) (VECTASHIELD; Vector Laboratories).
Images were obtained either with the Zeiss Axioskop 2
microscope or with a Leica TCS confocal laser-scanning
microscope. Adobe Photoshop version 7.0 (Adobe Systems,
Inc.) was used to process the images.
Cell counting
Whole pancreata of wild-type embryos and Prox1/
littermates were sectioned (8 Am), and each third (E9.5) or
fifth (E10.5 and E11.5) consecutive section was incubated
with antibodies recognizing specific molecular markers
(Prox1 in wild-type tissues, h-galactosidase in Prox1/
tissues, Ki67, bromodeoxyuridine [BrdU], Cdkn1b, Islet1,
Ngn3, glucagon, or cholecystokinin [Cck]) to estimate the
percentage of cells that expressed each marker in the entire
pancreas. The number of Prox1+ and h-gal+ cells was an
estimate of the total number of pancreatic cells in wild-type
and Prox1/ pancreata, respectively.
In situ hybridization
Digoxigenin-labeled antisense mRNA probes were tran-
scribed in vitro by using plasmids kindly provided by D.
Anderson (neurogenin 3 [Ngn3]), M.J. Tsai (NeuroD/
Beta2), J. Jensen (Hes-1), J. Hald (Notch1), and U. Lendahl
(Notch2). The production of Pax4 antisense riboprobes was
previously described (Wang et al., 2004). The probes were
used for nonradioactive in situ hybridization on 12-Am
frozen sections as previously described (Wang et al., 2004).
BrdU staining
Pregnant females were injected with BrdU (100 Ag/g of
body weight) at E11.5 of gestation. Embryos were dissected
2 h later and processed for cryosectioning as previously
described. Frozen sections were incubated in blocking
solution (20% fetal bovine serum and 2% Boehringer
Blocking Powder) for 30 min, washed with Tris-buffered
saline with 0.1% Tween-20, incubated in 2 N HCl for 15
min and rinsed four times with 0.1 M sodium borate
solution (pH 8.5). After this rinsing, sections were incubated
with anti-BrdU antibody overnight and then with secondary
Cy3-labeled anti-mouse IgG antibody for 3 h.
Microarray analysis
Gene expression analyses were performed at the Hartwell
Center for Bioinformatics and Biotechnology at St. Jude
Children’s Research Hospital. The Affymetrix MOE-430A
GeneChip array, which contains probes for 14,484 well-
characterized mouse genes, was used in the analysis. Dorsal
pancreata from four E12.5 wild-type embryos and fourProx1/ littermates were dissected. After genotyping,
pancreata of the same genotype were pooled, and RNA
was extracted. Total RNAwas prepared by using the TRIzol
method (Invitrogen) and quantified by spectrophotometry.
An Agilent 2100 Bioanalyzer evaluated RNA quality (i.e.,
the integrity and relative abundance of the 28S and 18S
ribosomal RNAs). Two hundred nanograms of total RNA
were subjected to two rounds of linear amplification as
described in the Affymetrix small-sample version 2.0
protocol. Briefly, RNA was annealed to a T7-oligo(dT)
primer, and double-stranded cDNA was generated by using
the SuperScript II cDNA synthesis kit according to the
manufacturer’s instructions (Invitrogen). After ethanol
precipitation, the cDNA, which served as a template, and
the MEGAscript T7 kit (Ambion) were used to synthesize
cRNA. After purification, 400 ng of cRNA served as the
starting template for a second round of cDNA synthesis in
which random hexamers initiated reverse transcription and
the T7-oligo(dT) primer completed second-strand synthesis.
The resulting cDNA was ethanol precipitated and used as a
template to generate biotin-labeled cRNA (T7 RNA
polymerase-based Bioarray HighYield RNA Transcript
Labeling Kit; ENZO Diagnostics, Inc). Ten micrograms of
biotin-labeled cRNA was fragmented by heating and metal-
induced hydrolysis, added to a hybridization cocktail that
contained probe array controls and blocking agents, and
incubated overnight at 45-C on a GeneChip array. After
hybridization, a GeneChip Fluidics Station 400 washed the
arrays automatically under high-stringency conditions to
remove nonhybridized labeled cRNA. Arrays were incu-
bated with R-phycoerythrin conjugates of streptavidin
(SAPE, Molecular Probes), washed, and incubated with
biotin-conjugated anti-streptavidin antibody. After removal
of the antibody solution, the arrays were restained with
SAPE, washed again, and scanned by the Affymetrix
GeneChip Scanner 3000. Expression signals for each gene
were calculated by the Affymetrix GCOS software (version
1.1) that uses the global scaling method with the 2%
trimmed average signal set to 500. By establishing values of
the wild-type sample as the baseline and by using the GCOS
software, we evaluated changes in gene expression. Detec-
tion and change calls for each probe set were determined by
using the default parameters of the software and as
recommended by the Affymetrix GeneChip protocol. To
compare gene expression at E12.5, we compared the
hybridization results of the wild-type sample with those of
the mutant sample.
RT-PCR
The total RNA isolated from four E12.5 wild-type or
Prox1/ pancreata was treated with RNAse-free DNAse
and then used with the Advantage RT-for-PCR kit (Clontech)
and random hexamer primers to synthesize cDNA. Two
microliters of this reaction product served as a template for
PCR using the following primers: amylase-specific forward
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primer, 5V-CTTCTTTTGTTACTCCATTG-3V; Cck-specific
forward primer, 5V-GCACTGCTAGCGCGATACAT-3V, and
reverse primer, 5V-GGCTGAGATGTGGCTGCATT-3V; and
cyclophilin-specific forward primer, 5V-CAGGTCCTGG-
CATCTTGTCC-3V, and reverse primer, 5V-TTGCTGGTC-
TTGCCATTCCT-3V. During each cycle of PCR, the samples
were incubated at 94-C for 45 s, at 60-C for 45 s, and at 72-C
for 45 s. Twenty-eight cycles were conducted to amplify
cyclophilin cDNA; 40 cycles were performed to amplify Cck
cDNA; and 50 cycles were done to amplify amylase cDNA.
Amplification was followed by a 10-min period of extension
at 72-C.
Statistical analyses
The Student’s t test was used to compare the proportions
of cells that expressed markers of interest in Prox1+/+ andFig. 1. Temporal expression and distribution of Prox1 during development of the m
similarly expressed in the dorsal (arrowhead) and ventral (arrow) pancreatic regio
pancreatic epithelial cells, but a small number of cells located in large clusters (as
At E13.5, Prox1 proteins (red in panel C, green in panel D) were visible in cells
panel C) and in newly specified endocrine precursors (Ngn3+ cells, arrows and
abundant in cells expressing the pan-endocrine marker Isl1 (yellow, arrows), but P
E15.5, Prox1 protein (red) was expressed at high levels in clusters of cells (arrow
of exocrine acini. Conversely, in cells expressing the exocrine marker amylase (ar
In newborn pancreata, Prox1 was expressed at high levels in developing islets and
low levels in exocrine acini (asterisk). (H) In adult pancreata, the expression of
distributed within the exocrine tissue (ex). (I) In adult pancreatic islets, Prox1 (red
and at lower levels in the core of insulin-producing cells (arrows). (A–G, I) Froze
specific antibodies. (F and G) Cell nuclei were stained with DAPI. (H) Whole P
Ecad, E-cadherin; Ngn3, neurogenin3; hgal, h-galactosidase. Scale bars, 200 AmProx1/ pancreata. A P value < 0.05 indicated a statisti-
cally significant difference.
URLs
Complete details about the Affymetrix MOE-430A
GeneChip array are available at http://www.affymetrix.com.Results
Prox1 is widely expressed throughout the ontogeny of the
mouse pancreas
As previously reported (Burke and Oliver, 2002), Prox1
protein was expressed in the dorsal pancreatic anlagen of
E9.5 embryos (Fig. 1A); this expression was similar to that
of Pdx1 (Fig. 1AV), one of the earliest pancreatic markersouse pancreas. (A and AV) At E9.5, Prox1 (red, A) and Pdx1 (red, AV) were
ns. (B) At E13.5, Prox1 (red) and Pdx1 (green) were co-expressed in most
terisk) and within the epithelium (arrows) expressed only Prox1. (C and D)
undergoing mitosis (phospho-histone3+ [PH3+] cells, arrows and yellow in
yellow in panel D). (E) In E15.5 pancreata, Prox1 protein (green) was
rox1 expression in other regions of this tissue (arrowhead) was low. (F) At
head) and at medium or low levels (red arrow) in cells located at the center
rows and green), the levels of Prox1 proteins were very low or absent. (G)
ducts (arrows and pink) and in centroacinar cells (arrowhead), and at very
Prox1 was observed in islets (isl), in large ducts (dc), and in small ducts
) was expressed at high levels in cells located at the periphery (arrowhead)
n sections of the pancreata of wild-type embryos and of adults stained with
rox1+/ pancreas stained with X-gal. Confocal images are shown in B-E.
.
Fig. 2. Abnormalities of E15.0 Prox1-deficient pancreata. (A, C, E, G) The
pancreata of E15.0 Prox1+/ (A) and wild-type (C, E, G) embryos had
numerous branches (arrows in panels A and C). E15.0 wild-type pancreata
also have regions of pseudostratified epithelium (arrows in panels E and G).
Large clusters of cells containing abundant cytoplasm are also visible in the
vicinity of the pancreatic epithelium or emerging from it (arrowheads in
panel G). (B, D, F, H) In contrast, E15.0 Prox1/ pancreata were smaller
(compare panel A with B) and almost devoid of branches (arrows in panels
B and D). E15.0 Prox1/ pancreata appeared to be less developed than
those of wild-type littermates, because it contained large portions of poorly
stratified epithelium with a ductal appearance (arrows in panel F) and
smaller endocrine cell aggregates (arrowheads in panel H). (A and B)
Whole pancreata of Prox1+/ (A) and Prox1/ (B) embryos stained with
X-gal. (G and H) Paraffin sections of E15.0 wild-type (G) or Prox1/ (H)
embryos stained with hematoxylin–eosin. (C–F) Frozen sections stained
with antibody to E-cadherin (green) and with a nuclear marker (propidium
iodide, red in panels C and D; DAPI, blue in panels E and F). Scale bars,
200 Am.
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1996). Later in development, co-expression of Pdx1 and
Prox1 proteins was detected in most of the E13.5 pancreatic
epithelium (Fig. 1B), with the exception of a few isolated
cells and of cells arranged in clusters that expressed Prox1
but were devoid of Pdx1 immunoreactivity (Fig. 1B). In
E13.5 pancreata, we detected Prox1 immunoreactivity in
proliferating cells (identified by expression of the mitotic
marker phosphohistone 3; Fig. 1C) and in newly specified
endocrine precursors that expressed the basic helix–loop–
helix protein neurogenin3 (Ngn3) (Fig. 1D) (Wilson et al.,
2003). Starting at around E15.5, endocrine cells (identified
by expression of the pan-endocrine marker islet1 [Isl1];
Ahlgren et al., 1997) expressed high levels of Prox1 protein
(Fig. 1E), but in differentiating exocrine cells the expression
of Prox1 was nearly absent (Fig. 1F). In newborn pancreata,
high levels of Prox1 were detected in ducts from which
endocrine islets seemed to emerge, in cells located at the
periphery of these islets, and in centroacinar cells (Fig. 1G).
In contrast, cells that were located at the core of the islets
and corresponded to insulin-producing beta cells expressed
only moderate levels of Prox1; pancreatic exocrine acini
were almost devoid of this protein (Fig. 1G). The same
expression profile remained in adult pancreata (Figs. 1H and
I). Previous studies demonstrated that the activity of Prox1
is essential for the appropriate formation of various organs
(Dyer et al., 2003; Sosa-Pineda et al., 2000; Wigle and
Oliver, 1999; Wigle et al., 1999). Therefore, we hypothe-
sized that Prox1 also controls certain aspects of pancreatic
ontogeny. To investigate this premise, we undertook an
extensive molecular analysis of Prox1-deficient pancreata.
Loss of functional Prox1 disrupts pancreas morphology
The death of Prox1/ embryos at approximately E15.0
is probably the result of multiple developmental alterations
(Wigle et al., 1999). In wild-type embryos at this stage, the
pancreatic epithelium has developed numerous branches
that normally harbor a mixed population of undifferentiated
and differentiating precursors (Figs. 2A and C). The
histological and immunohistochemical analyses of E15.0
wild-type pancreata revealed regions of stratified epithelium
(Figs. 2E and G) and large, eosinophilic cell aggregates
emerging from the basolateral side of this tissue (Fig. 2G).
In contrast, E15.0 Prox1-deficient pancreata were smaller
than those of wild-type or heterozygous embryos and almost
entirely lacked branches (Figs. 2B and D). In addition, the
pancreata of E15.0 Prox1/ littermates not only appeared
underdeveloped but also possessed large areas of simple
columnar epithelium with a ductal appearance (Figs. 2D and
F). Likewise, in these mutant tissues the majority of
eosinophilic clusters were smaller than those of wild-type
littermates (compare Fig. 2G with H). Together, these
alterations indicate that Prox1 activity is required to control
the size and appropriate morphogenesis of the normal
pancreas.Loss of functional Prox1 hinders pancreatic growth
Our analysis of E9.5 Prox1-nullizygous mice did not
show obvious alterations in the morphology or size of the
pancreatic anlagen (Figs. 3A and D). However, after E11.5
the pancreatic tissues of Prox1-nullizygous mice were
consistently smaller than those of wild-type littermates
(Figs. 3B and E). Moreover, quantitative analysis of
pancreatic epithelial cells (i.e., Prox1-positive cells of
wild-type pancreata [Fig. 3B] or h-galactosidase [h-gal]-
positive cells of Prox1/ pancreata [Fig. 3E]) revealed that
the size of the E11.5 Prox1-nullizygous pancreas was
approximately 63% of that of wild-type littermates
(7162 T 899 cells [wild type] vs. 4560 T 560 cells
Table 1
Endocrine cell counting
Stage Marker No. of positive cells
Wild type Prox1/ n
E9.5a Islet1 26 30 1
E10.5b Islet1 104 107 1
E11.5c Islet1 191.3 T 47.4 161.0 T 45.4 3
E11.5b Ngn3 28 (7.5)d 22 (7.4)d 1
E11.5a Pax6 263.0 T 93.6 (18.3 T 3.6)e 174.7 T 29.0 (19.3 T 3.4)e 3




d Percentage of Ngn3+ cells in the entire pancreatic cell population (as
determined by the total number of Prox1+ cells of wild-type tissue or h-gal +
cells of Prox1/ tissue).
e Percentage of Pax6+ cells in the entire pancreatic cell population.
Fig. 3. Lack of Prox1 activity arrests pancreatic growth at around E11.5.
(A–F) Frozen sections of wild-type (A–C) and Prox1/ (D–F)
pancreata. (A and E) At E9.5, the expression of Pdx1 (red, arrow) was
indistinguishable between dorsal pancreata of wild-type (A) and Prox1/
(D) embryos. (B and E) At E11.5, Prox1 (red in panel B) was detected in
all pancreatic cells of wild-type embryos, and h-gal was detected in all
pancreatic cells of Prox1/ embryos (red in panel E). (G) By estimating
the total number of cells that expressed Prox1 (wild type) or h-gal
(Prox1/), we determined that the size of E11.5 Prox1/ pancreata was
approximately 63% of that of wild-type pancreata. (H) The proliferation
index (i.e., the percentage of Ki67+ cells or of cells that incorporated
BrdU) in E11.5 Prox1/ pancreata was not significantly different than
that in pancreata of wild-type littermates. (H) However, in E11.5 Prox1/
pancreata, the proportion of cells that expressed Cdkn1b, an indicator of
exit from the cell cycle (red in panels C and F), was almost twice that in
wild-type pancreata. (B, C, E, F) Pancreatic epithelia were stained with
antibody to E-cadherin (green). Asterisks indicate statistically significant
differences (i.e., P < 0.05 in comparisons of mutant and wild-type tissues);
n.s. indicates differences that were not statistically significant (as
determined by the Student’s t test). Scale bars, 200 Am.
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determine whether the reduced size of Prox1-deficient
pancreatic tissues was the result of defective proliferation,
we compared the proliferation index (i.e., the proportion of
cells that expressed Ki67 or that incorporated BrdU) between
E11.5 Prox1/ pancreata and wild-type pancreata. Our
results showed no significant difference in the proliferation
index of E11.5 Prox1/ pancreata (Ki67: 78.5% T 1.5%
[wild type] vs. 75.6% T 0.4% [Prox1/]; P = 0.36. BrdU:
33.5% T 2.8% [wild type] vs. 29.1% T 3.2% [Prox1/]; P =
0.37; 3 embryos per group) (Fig. 3H). Similarly, the reduced
size of Prox1/ pancreata also did not seem to result from
increased cell death, as no overt apoptosis was detected inthese mutant tissues between E11.5 and E15.0 (data not
shown). In contrast, our quantitative analysis showed a
significant increase (by a factor of approximately 1.8) in the
proportion of cells that expressed the cell cycle-exit indicator
Cdkn1b in E11.5 Prox1-deficient pancreatic tissues (9.1% T
1.3% [wild type] vs. 15.2% T 1.9% [Prox1/]; P < 0.01; 3
embryos per group) (Figs. 3C, F, H). Cdkn1b (also known as
p27Kip1) is a cyclin kinase inhibitor of the Cip/Kip family that
causes cell cycle arrest by blocking phosphorylation of the
retinoblastoma protein (Fero et al., 1996; Kiyokawa et al.,
1996; Nakayama et al., 1996; Sherr and Roberts, 1995). This
result raises the possibility that the inability of some epithelial
progenitors to undergo additional rounds of cell division
contributed to the decrease in size of the Prox1-deficient
pancreata.
In early pancreatic tissues, the activity of Notch main-
tains the undifferentiated state of progenitors and, con-
versely, the absence of Notch activity prevents pancreatic
growth by promoting en masse endocrine differentiation of
most pancreatic progenitors (Apelqvist et al., 1999; Esni et
al., 2004; Hald et al., 2003; Jensen et al., 2000; Murtaugh et
al., 2003). Therefore, one possible explanation for the
reduced size of Prox1-deficient pancreatic epithelia is that
the absence of Prox1 activity disrupted Notch signaling.
However, this possibility seems unlikely because in Prox1-
deficient pancreata we did not detect a substantial increase
in the number of Isl1+ cells between E9.5 and E11.5
(Supplementary Figs. 1A, B, D, E, and Table 1), in the
proportion of Pax6+ cells at E11.5 (18.3% T 3.6% of wild-
type vs. 19.3% T 3.4% of Prox1/ embryos; P = 0.4; 3
embryos per group; Table 1), or in the proportion of Ngn3+
endocrine progenitors at E11.5 (Supplementary Figs. 1C, F,
and Table 1). Moreover, by using in situ hybridization, we
found that the expression of three components of the Notch
signaling pathway (Notch1, Notch2, and Hes-1; Lammert et
al., 2000) was comparable between pancreata of E13.5–
E14.5 wild-type embryos and Prox1-nullizygous littermates
(Supplementary Fig. 2).
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of Prox1-deficient pancreatic tissues did not result from
defective cell proliferation or from the absence of Notch
activity. However, it is possible that the arrest in this organ’s
growth resulted in part from premature withdrawal of
epithelial progenitors from the cell cycle, as indicated by
the increase in the proportion of cells that expressed
Cdkn1b/p27 in Prox1-deficient pancreata at E11.5.
Comparative microarray analysis revealed increased
expression of Cck (cholecystokinin) in Prox1-deficient
pancreata
To identify additional alterations in gene expression that
resulted from the lack of pancreatic Prox1 activity, we
conducted a comparative gene-profiling analysis by using
dorsal pancreata dissected from E12.5 wild-type and Prox1-
nullizygous embryos. After hybridizing wild-type and
mutant cRNAs to an Affymetrix MOE-430A GeneChip
and comparing the results of the hybridization as described
in the Materials and methods section, we created a list of
genes whose expression was consistently increased or
decreased by more than a factor of 2.0 in the Prox1-
deficient pancreata (Table 2, Supplementary data). Overall,
these results did not show significant alterations in the
expression of genes encoding products known to be
required for cell proliferation. In contrast, our microarray
results indicated a significant enrichment (by a factor of
approximately 5.7) of Cck transcripts in RNA isolated from
Prox1-nullizygous mice (Table 2, Supplementary data). In
wild-type mice, the hormone Cck is largely produced byFig. 4. A population of early pancreatic endocrine cells expressed cholecys
immunoreactivity (red in panel A) largely colocalized with Prox1 protein (green
devoid of Prox1 immunoreactivity). (B) In contrast, most Cck+ cells (red) did not e
to a Cck+ cell that co-expressed a low level of Pdx1 protein). (C) In pancreatic tissu
pan-endocrine marker Isl1 (green; arrows indicate colocalization of Cck and Isl1 pr
cells (green in panel D and red in panel E) largely co-expressed glucagon (arrows
ghrelin (arrow in panel D). (F–H) In pancreatic tissues of E18.5 embryos, Cck
colocalized with glucagon (red in panel F, arrows). In contrast, at this stage Cck di
cells) or somatostatin (green in panel H; arrows point to Cck+/somatostatin cells
stained with DAPI. Scale bars, 400 Am.mature enteroendocrine duodenal cells (Rindi et al., 2004).
In addition, expression of Cck has also been observed in a
few cells of the mouse pancreata toward the end of gestation
and at postnatal stages (Liu et al., 2001). To our knowledge,
no studies have shown that Cck is expressed early in
pancreas development. Thus, by using immunohistochem-
istry, we sought to characterize the expression of Cck in
pancreatic tissues of wild-type mouse embryos between
E11.5 and E18.5 (Fig. 4).
The differentiation of various types of pancreatic endo-
crine cells occurs in a time-restricted manner (Pictet and
Rutter, 1972; Slack, 1995). Between E9.5 and E12.5 in
mouse development, an early wave of differentiation
produces endocrine cells that synthesize mainly glucagon,
although a reduced number of early pancreatic endocrine
cells also express ghrelin, insulin, or islet amyloid polypep-
tide, either alone or in combination with glucagon (Pictet
and Rutter, 1972; Wilson et al., 2002; Prado et al., 2004).
We have now determined that a small population of Cck-
expressing cells is also present at around E11.5 in the mouse
pancreata (Figs. 4A–E). In these tissues, a few Cck-positive
cells were found scattered throughout the pancreatic
epithelium; however, the majority of Cck+ cells appeared
associated with clusters of cells (Figs. 4A–E). The
association of pancreatic Cck+ cells with large endocrine
cell clusters was also observed at E13.5 (Fig. 5D). Previous
studies of cell lineage showed that all pancreatic epithelial
cells originate from Pdx1+ precursors (Gu et al., 2002). In
E11.5 wild-type pancreatic tissues, we found that most Cck+
cells co-expressed Prox1 proteins (Fig. 4A), and conversely
the majority of Cck-expressing pancreatic cells did nottokinin (Cck). (A–E) In the pancreata of E11.5 mouse embryos, Cck
in panel A; arrows indicate colocalization; arrowhead indicates a Cck+ cell
xpress Pdx1 (green; arrowheads indicate Cck+/Pdx1 cells; the arrow points
es, Cck-expressing cells (red) were endocrine because they all expressed the
oteins; the asterisks point to Isl1+/Cck cells). (D and E) Additionally, Cck+
in panel E; arrowheads point to glucagon+/Cck cells) or, in rare occasions,
immunoreactivity (red in panel H and green in panels F and G) largely
d not co-localize with insulin (red in panel G; arrows point to Cck+/insulin
and arrowhead points to somatostatin+/Cck cells). (C–H) Cell nuclei were
Fig. 5. The absence of Prox1 activity alters the differentiation of early pancreatic endocrine precursors. (A and B) At E11.5, a large fraction of pancreatic
endocrine cells expressed glucagon (A, green and arrows), and a small percentage expressed Cck (B, red and arrows). (E–H) The absence of Prox1 activity
did not preclude the formation of early pancreatic endocrine cells or their aggregation into clusters (arrows in panels E and F and arrowheads in panels G and
H). However, early endocrine differentiation was affected by the absence of Prox1 function: in E11.5 Prox1/ pancreata, more endocrine cells expressed
Cck (F and J) than glucagon (E and I). This alteration was also observed at E13.5 in Prox1/ pancreata (compare the expression of Cck [red] between wild-
type [arrow and arrowhead in panel D] and Prox1/ pancreata [arrow and arrowhead in panel H], and that of glucagon [red] between wild-type [arrow and
arrowhead in panel C] and Prox1/ [arrow and arrowhead in panel G] pancreata). (A–H) Pancreatic epithelia were stained with antibody to E-cadherin
(green in panels B–D, F–H; red in panels A and E). Asterisks indicate statistically significant differences (i.e., P < 0.05 in comparisons of mutant and wild-
type tissues); n.s. indicates differences that were not statistically significant (as determined by the Student’s t test). Scale bars, 200 Am.
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of Cck follows a rapid decline in the level of Pdx1 proteins
in pancreatic tissues. In addition, pancreatic Cck-expressing
cells are largely post-mitotic; that is, they do not co-express
the mitotic marker phospho-histone3 (data not shown). Not
surprisingly, Cck-expressing pancreatic cells appeared to be
endocrine cells-all co-expressed islet1 (Fig. 4C). Moreover,
most Cck+ cells in embryonic pancreatic tissues co-
expressed glucagon (Fig. 4E) or, occasionally, ghrelin
(Fig. 4D). This observation is consistent with previous
reports that indicated that cells expressing multiple hor-
mones are present in early pancreatic tissues of mouse
embryos (Herrera, 2002; Prado et al., 2004; Wilson et al.,
2002). Although numerous pancreatic Cck+ cells also co-
expressed glucagon at E18.5 (Fig. 4F), colocalization of
Cck and ghrelin proteins was rare in these tissues (data not
shown), and we did not detect co-expression of either of
Cck and insulin or Cck and somatostatin (Figs. 4G and H).
Hence, these results suggest that Cck+ pancreatic cells
represent a subpopulation of alpha (i.e., glucagon-express-
ing) cells.
Remarkably, the proportion of Cck-expressing cells was
larger in the pancreata of E11.5 Prox1/ embryos than
that in the pancreata of wild-type littermates (7.1% T 3.9%[wild type] vs. 17.1% T 2.7% [Prox1/]; P = 0.01; 3
embryos per group) (Figs. 5B, F, J). This increase did not
seem to result from an abnormal expansion of the
population of endocrine cells because E11.5 Prox1-
deficient pancreata also had proportionately fewer gluca-
gon-synthesizing cells than their wild-type counterparts
(18.1% T 5.2% [wild type] vs. 11.1% T 2.1% [Prox1/];
P=0.049; 3 embryos per group) (Figs. 5A, E, I). This
altered proportion of Cck+ and glucagon+ cells was also
observed in E13.5 Prox1-deficient pancreata (compare
Figs. 5C and D with Figs. 5G and H). Together, these
results suggest that although Prox1 activity is dispensable
for the formation of early pancreatic endocrine cells, it
probably influences cell fate decisions by antagonizing the
expression of hormones normally enriched in more
posterior regions of the gastrointestinal tract.
Loss of functional Prox1 affects islet cell genesis
In mouse embryos, a second wave of pancreatic endocrine
differentiation (the ‘‘secondary transition’’) commences at
around E13.5 and persists throughout gestation (Pictet and
Rutter, 1972). During this period, the pancreatic precursors
gradually differentiate into one of the four main types of
J. Wang et al. / Developmental Biology 286 (2005) 182–194190islet cells (Pictet and Rutter, 1972; Murtaugh and Melton,
2003). In wild-type embryos at this stage, the pancreatic
endocrine cell population is composed of large clusters of
hormone-producing/Isl1+ cells located towards the baso-
lateral side of the pancreatic epithelium (arrowheads in
Figs. 5C, D, and 6A), scattered endocrine cells (Isl1+)
(arrows in Fig. 6A), and numerous, newly specified
endocrine precursors (Ngn3+) that appear dispersed
throughout most of the epithelium (Fig. 6C). In the
pancreata of E13.5 Prox1-deficient embryos, some Isl1+
cell clusters were still present (arrowhead in Fig. 6B);
however, only a small number of individual endocrine
(Isl1+) cells or very few endocrine precursors (Ngn3+) were
detected in these mutant tissues (Figs. 6B and D). This
observation suggests that after E13.5, the loss of pancreatic
Prox1 reduces the production of islet cell precursors. To
further investigate this possibility, we compared the
expression of two other early endocrine markers (NeuroD
and Pax4; Wilson et al., 2003) or that of insulin between
E13.5 and E14.5 wild-type and Prox1/ pancreata.
Accordingly, while numerous cells of wild-type pancreata
expressed any of those three markers (Figs. 6G, I, K), a
substantial reduction in the number of cells expressing
NeuroD (Fig. 6H), Pax4 (Fig. 6J), or insulin (Fig. 6L) was
observed in E14.0–E14.5 Prox1-deficient pancreata.Fig. 6. The formation of endocrine cells in Prox1-deficient pancreatic tissues de
embryos, two distinct populations of endocrine cells (Isl1+ cells) are present: thos
the epithelium (arrows). (B) While E13.5 Prox1/ pancreata still had some aggr
within the epithelium (arrows). (C) In wild-type pancreata, the production of end
E13.5. At E14.0, numerous endocrine precursors expressed NeuroD (arrows in
differentiate into insulin-producing beta cells (red and arrows). Conversely, the p
endocrine progenitors (arrows in panel D) and only a very small number of cells
(arrows in panel L). The pancreatic epithelia were visualized by staining with anti-
L). (K and L) Anti-insulin antibodies were used to stain differentiating beta cells.
detected by digoxigenin-labeled antisense probes. Sequential, adjacent sections arTogether, these results indicate that after E13.5 the activity
of Prox1 is necessary for the genesis of pancreatic islet cell
precursors, for their maintenance, or for both processes.
Loss of functional Prox1 increases exocrine cell genesis
The results of our microarray analysis revealed a
substantial, abnormal increase in exocrine-specific tran-
scripts in the pancreata of E12.5 Prox1-deficient embryos
(e.g., amylase [Amy2] transcripts were increased by a factor
of 2.5; serine protease 2 [Prss2], by a factor of 3.0–48.5; and
trypsin 4 [Try4], by a factor of 3.0 [Table 2, Supplementary
data]). By using semi-quantitative RT-PCR, we further
confirmed that the loss of pancreatic Prox1 activity notice-
ably increased the expression of amylase RNA at E12.5 (Fig.
7A). These results raised the possibility that, contrary to its
effects on islet cell genesis, the loss of Prox1 activity in
pancreatic tissues increases the production of exocrine cells.
To test this hypothesis, we analyzed the expression of various
exocrine markers in the pancreata of Prox1-nullizygous
embryos and wild-type littermates at E13.5 or E14.5.
In E13.5–14.5 pancreata, the population of endocrine,
islet cell precursors (Isl1+) normally disperses within a
broad ‘‘endocrine territory’’ distinguished by the expression
of the homeodomain transcription factor Nkx6.1 (Figs. 7Bcreases considerably after E13.5. (A) In the pancreata of E13.5 wild-type
e that form large aggregates (arrowhead) and those that are scattered within
egates of endocrine cells (arrowhead) only a few Isl1+ cells were dispersed
ocrine progenitors (Ngn3+ cells, arrows) increased significantly at around
panel G) or Pax4 (I). (K) At E14.5, some endocrine precursors started to
ancreata of E13.5–E14.5 Prox1-deficient embryos had significantly fewer
expressed NeuroD (arrows in panel H), Pax4 (arrows in panel J), or insulin
laminin antibodies (A and B) or anti-E-cadherin (Ecad) antibodies (E, F, K,
Transcripts for Ngn3 (C and D), NeuroD (G and H) or Pax4 (I and J) were
e shown in panels C and E and in panels D and F. Scale bars, 100 Am.
Fig. 7. Exocrine cells differentiate prematurely in Prox1-deficient pancreatic tissues. (A) RT-PCR analysis of E12.5 wild-type and Prox1/ pancreata confirmed
the microarray results that indicated increased transcription of amylase (Amy) and cholecystokinin (cck) in E12.5 Prox1-deficient tissues. (B and C) In the
pancreatic epithelia of E14.5 wild-type embryos, Isl1+ cells (arrows in panel C) appeared to be included within an ‘‘endocrine territory’’ that expressed Nkx6.1
protein (orange and arrows in panel B). In contrast, the tips of the branches that were largely devoid of Nkx6.1 immunoreactivity (arrowheads in panel B) had
numerous cells that expressed the exocrine marker p48 (arrowheads in panel C). In these tissues, endocrine cells (Isl1+ cells, arrows and green in panel C) clearly
outnumbered exocrine cell precursors (p48+, red and arrowheads in panel C). Conversely, the domain of Nkx6.1 expression in the pancreata of E14.5 Prox1-
deficient embryos (orange and arrows in panel E) was reduced andwas virtually absent at the periphery of these epithelia (arrowheads in panel E). Also, the ratio of
Isl1+ cells to p48+ cells in these mutant tissues was inverted in comparison with the ratio in pancreata of wild-type littermates (compare panel C with F). (D and G)
Few exocrine cells (amylase+) were visible in the pancreatic epithelia of E14.5 (arrows in panel D) wild-type embryos. In contrast, the population of exocrine cells
(amylase+; orange and arrows in panel G) was abnormally increased in the pancreata of E14.5 Prox1-deficient embryos. In (B, D, E, G) pancreatic epithelia were
visualized by staining with anti-E-cadherin antibodies (green). (C and F) Green arrows indicate Isl1 expression in mesenchymal cells. In (B and E) the image of
Nkx6.1 staining was enhanced to show areas of low-level and high-level immunoreactivity. Scale bars, 100 Am.
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population of exocrine precursors (expressing the basic
helix-loop-helix transcription factor p48) localizes to the tip
of the elongating branches (arrowheads in Figs. 7B and C)
and is largely excluded from areas expressing Nkx6.1
(arrows in Fig. 7B) or Isl1 (arrows in Fig. 7C) (Krapp et al.,
1998; our own observations). Unexpectedly, in E14.5
Prox1/ pancreata the domain of Nkx6.1 expression was
more restricted (arrows in Fig. 7E), there were significantly
fewer Isl1+ cells (arrows in Fig. 7F), and those areas devoid
of Nkx6.1 immunoreactivity (arrowheads in Fig. 7E)
contained numerous cells that expressed p48 (arrowhead
in Fig. 7F). Accordingly, in pancreatic tissues of Prox1-
nullizygous embryos isolated between E13.5 and E14.5, we
observed a substantial increase in the number of pancreatic
cells that expressed the exocrine differentiation markers
carboxypeptidase A (data not shown) or amylase (compare
Fig. 7D with G). Altogether, these results raise the
intriguing possibility that the loss of Prox1 activity favors
exocrine cell genesis at the expense of the production of
new islet cell precursors.
Of note, our microarray data also indicated reduced
expression of neurogenin3 (1.87) and Nkx6.1 transcripts
(9.8-fold, ‘‘Absent’’ call) and increased expression of
Ptf1/p48 (+1.7) in Prox1-deficient pancreata already at
E12.5. However, these specific alterations were not
indicated in Table 2 in the Supplementary data sectionbecause this table includes only 2-fold changes or ‘‘Present’’
calls.Discussion
Prox1 activity controls pancreatic growth and pancreas
morphogenesis
In this study, we showed that Prox1 is expressed in
nearly all pancreatic progenitor cells early in development
whereas in pancreatic tissues of late-gestation embryos or
adults, Prox1 expression becomes restricted to endocrine
islets and to cells located within ducts. The extensive
expression of Prox1 in early pancreatic tissues suggests an
involvement of Prox1 activity in the specification of
pancreatic progenitors, in their proliferation, or in both
processes. However, our analysis of Prox1-deficient mouse
embryos revealed that Prox1 activity is dispensable for
pancreas specification because in the absence of Prox1 the
initial stages of pancreas organogenesis (i.e., the formation
of the dorsal and ventral pancreatic primordia) proceeded
normally. Conversely, a prominent delay in pancreatic
growth occurred in Prox1-deficient embryos after E11.5.
As a result, Prox1-nullizygous mice had considerably
smaller pancreata at the time of their death (at around
E15.0) than did their wild-type littermates. In addition, these
J. Wang et al. / Developmental Biology 286 (2005) 182–194192mutant tissues had severely impaired morphology: they
almost entirely lacked branches and the epithelia appeared
to be poorly developed. Thus, our studies determined that
Prox1 activity supports pancreatic growth and is also
required for appropriate pancreas morphogenesis.
Does Prox1 prevent premature withdrawal of progenitors
from the cell cycle?
The lack of pancreatic Prox1 function hindered epithelial
growth and prevented the elongation of branches. These two
alterations could indicate defective cell proliferation,
because previous studies showed that the expansion of the
pancreatic primordia and the formation of branches require
cell division (Edlund, 2002; Horb and Slack, 2000). Despite
this evidence, the results of our comparative microarray
analysis did not show any major alterations in the
expression of genes encoding cell cycle regulators or
components of growth-promoting signaling pathways in
the pancreata of E12.5 Prox1-deficient embryos (Table 2,
Supplementary data). Additionally, our quantitative analyses
did not show significant differences in the proliferation
index between pancreatic tissues of E11.5 Prox1-deficient
embryos and their wild-type littermates (Fig. 3H). Overall,
the results of these studies indicate that Prox1 does not
participate in promoting cell proliferation or cell survival of
early pancreatic cells.
Conversely, in E11.5 Prox1-deficient pancreata there was
an increase in the fraction of cells that expressed Cdkn1b/
p27 protein. Interestingly, a number of studies of cultured
cells have shown that the expression of Cdkn1b increases in
response to extracellular anti-proliferative signals (Fero et
al., 1996; Nourse et al., 1994). Therefore, we could
hypothesize that in pancreatic progenitors Prox1 normally
enables additional rounds of cell division by antagonizing
anti-proliferative signals. Alternatively, Prox1 activity could
directly increase or stabilize the expression of Cdkn1b/p27
or could contribute to the increase in the pool of pancreatic
cells by stimulating the formation of progenitors with self-
renewal capacity. Although it is not clear how the activity of
Prox1 in pancreatic tissue would prevent the accumulation
of Cdkn1b/p27 protein (thereby allowing further rounds of
cell division), it is intriguing that in other types of progenitor
cells (e.g., neural cells and lens cells) Prox1 or its
Drosophila homolog prospero does not prevent but rather
promotes cell cycle exit (Torii et al., 1999; Wigle et al.,
1999; Li and Vaessin, 2000; Cremisi et al., 2003).
Conversely, in Drosophila glial cell precursors, prospero
prevents cell cycle withdrawal by antagonizing the expres-
sion of Dacapo, a Cdkn1b homolog (Griffiths and Hidalgo,
2004). Thus, it appears that the influence of Prox1 function
(or that of prospero) on cell cycle progression during
development is largely dependent on the cell-type context.
Although the lack of antibodies suitable for double-
labeling experiments precluded the identification of those
Cdkn1b/p27+ cells present in developing pancreatic tissue,we speculate that at least some of these cells represent post-
mitotic endocrine progenitors. In support of this proposal,
Cdkn1b/p27 immunoreactivity was detected within large
cell aggregates that also expressed Isl1 in the pancreata of
E11.5 Prox1-deficient or wild-type mice. Notwithstanding
this evidence, it is also possible that some pancreatic
Cdkn1b/p27+ cells may also represent exocrine progenitors
withdrawing prematurely from the cell cycle. Indeed, our
microarray data indicated increased differentiation of exo-
crine progenitors as early as E12.5 in the absence of Prox1
activity (Table 2, Supplementary data).
Previous studies in Xenopus and mice have shown that
Cip/Kip kinase inhibitors have dual roles in certain tissues:
the inhibitors not only promote cell cycle exit, but also
enable differentiation of cells into specific subtypes. For
example, in Xenopus retinal progenitors, the maintenance of
high levels of p27Xic1 proteins (the homolog of Cdkn1b)
promotes a ‘‘late’’, amacrine cell fate (Ohnuma et al., 1999).
In retinal progenitors of mice, Cdkn1c/p57 plays two roles:
first, it acts as a cyclin kinase inhibitor in dividing cells, and
later it promotes the amacrine interneuronal cell fate of
progenitors (Dyer and Cepko, 2000). Thus, it is possible that
the abnormal, premature accumulation of Cdkn1b/p27
proteins in Prox1-deficient pancreata not only promotes
premature cell cycle exit of progenitors, but also enables the
‘‘Cck’’ type of differentiation of these cells. The possibility
that Prox1 activity influences endocrine cell fate decisions
in early pancreatic tissues is similar to the previously
reported function of Prox1 in retinal tissues: Prox1 not only
induces the exit of retinal progenitor cells from the cell
cycle, but also specifies the fate of horizontal cells (Dyer et
al., 2003).
Our microarray results revealed an anomalous increase in
transcripts encoding gastric inhibitory peptide (Gip, another
hormone normally enriched in enteroendocrine duodenal
cells; Rindi et al., 2004) and reduced expression of glucagon
(1.74; data not shown) and islet amyloid polypeptide
(2.64 and 4.0) in E12.5 Prox1-deficient pancreata (Table
2, Supplementary data). Unfortunately, we could not verify
whether an abnormal increase in the number of Gip-
producing cells also occurred in these mutant tissues,
because our immunohistochemical analyses failed to detect
low levels of this protein (data not shown). Likewise, we
could not perform a rigorous, quantitative comparative
analysis of IAPP expression between pancreata of Prox1-
deficient and wild-type littermates, because the number of
IAPP+ cells is small and varies in early (E10.5–E13.5)
pancreatic tissues. However, these specific alterations in
gene expression provide further support to our proposal that
the loss of Prox1 activity altered the differentiation of early
pancreatic endocrine precursors. Overall, the identification
of Prox1 as a transcription factor required to determine the
fates of various subtypes of pancreatic cells provides a
valuable tool to help in characterizing the molecular and
cellular events influencing cell fate decisions in the
developing pancreas.
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‘‘secondary transition’’
The lack of Prox1 activity did not seem to prevent
‘‘early’’ pancreatic endocrine cell genesis (i.e., the pro-
duction of those hormone-expressing cells formed between
E8.5 and E11.5 in mouse pancreatic tissues) (Murtaugh
and Melton, 2003; Wilson et al., 2002) or their aggregation
into clusters, as indicated by the normal expression of Isl1
in the pancreata of Prox1/ embryos between E9.5 and
E11.5 (Supplementary Fig. 1 and Table 1) (Ahlgren et al.,
1997). However, the increase in the fraction of Cck-
expressing endocrine cells and the concomitant decrease in
glucagon-expressing cells observed in E11.5–E13.5
Prox1/ pancreata suggest a specific requirement of
Prox1 activity in the establishment of ‘‘early’’ endocrine
cell fates. In contrast, the finding that after E13.5 Prox1-
deficient pancreata had a substantial decrease in the
number of Ngn3-, Pax4-, NeuroD-, or insulin-expressing
cells and a more restricted expression of Nkx6.1 also
indicated that in these mutant tissues endocrine cell genesis
was significantly affected during the period corresponding
to the ‘‘secondary transition’’.
Results of our combined microarray and immunohisto-
chemical analyses also identified a substantial increase in
the number of pancreatic exocrine cells in Prox1-nullizy-
gous embryos and a dramatic increase in exocrine-specific
transcripts as early as E12.5. Therefore, how did the
removal of Prox1 activity selectively reduce the number
of ‘‘late’’ endocrine precursors and simultaneously increase
exocrine cell genesis? One possible explanation for the
aforementioned results is that Prox1 activity normally
enables endocrine cell differentiation of pancreatic bipotent
progenitors (i.e., maintains or stabilizes Ngn3 expression)
by repressing exocrine cell differentiation (e.g., by antago-
nizing PITF1/p48 expression) or by counteracting signals
that normally promote exocrine cell differentiation in early
pancreatic tissues (Kim and Hebrok, 2001). This premise is
supported by our finding that the levels of Prox1 protein
during normal pancreas development remained high in
newly specified endocrine precursors but were markedly
reduced in cells that expressed early markers of exocrine
differentiation (e.g., amylase or elastase). In addition,
previous cell lineage studies using retroviral labeling of
pancreatic cells have also suggested the existence of
bipotent progenitor cells capable of producing both endo-
crine and exocrine cell progeny in pancreatic epithelia
(Fishman and Melton, 2002; Murtaugh and Melton, 2003).
Nonetheless, our results do not rule out the possibility that
Prox1 has entirely different functions in endocrine and
exocrine pancreatic precursors. For instance, while Prox1
could contribute to maintenance of Ngn3 expression in
newly specified endocrine precursors produced after E13.5,
in exocrine precursor cells Prox1 could stimulate additional
rounds of division before they began to differentiate. In this
case, the increment of exocrine cells observed in E13.5–E14.5 Prox1/ pancreata would be merely an indication of
premature differentiation of exocrine precursors as a result
of premature withdrawal from the cell cycle.
In summary, our studies identified Prox1 as a crucial,
novel regulator of multiple processes during early pancreas
organogenesis. First and foremost, we propose that the
activity of Prox1 is necessary to maintain an expanding pool
of undifferentiated pancreatic progenitor cells. In other
tissues, particularly the developing mammalian cortex,
maintaining the progenitor state of epithelial cells appears
necessary not only to ensure appropriate growth, but also to
generate cellular diversity (Cremisi et al., 2003; Bajjalieh,
2004). We conclude that the lack of Prox1 activity prevents
pancreatic growth and affects the cellular composition of
this tissue; therefore, Prox1 is a crucial component of a
genetic program that is destined to produce the cellular
complexity of the mammalian pancreas.Acknowledgments
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